Stifel Reiterates Buy Rating on Eliem Therapeutics (ELYM), Sees Positive Risk/Reward Ahead of Upcoming ETX-810 Readouts

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DGNX

Go back to Stifel Reiterates Buy Rating on Eliem Therapeutics (ELYM), Sees Positive Risk/Reward Ahead of Upcoming ETX-810 Readouts
(NASDAQ: ELYM) Delayed: 5.11 --0 (-0%)
Previous Close $5.11    52 Week High $ 
Open $5.11    52 Week Low $ 
Day High $5.11    P/E N/A 
Day Low $5.11    EPS $ 
Volume 50,339